Traded at BSE :Scrip Code :538965
Close :59.40
Concord Drugs profit rises 108.33% Sept15 quarter
An innovative product patented in India
JOHNSON & Johnson Ltd have zeroed in on Concord Drugs Ltd (CDL), a Hyderabad-based parenterals manufacturer, for the marketing of the latter’s sterile tissue adhesive, an innovative product patented in India, under its own brand.
Johnson & Johnson India Ltd had agreed in principle to confer an order on Concord Drugs for the manufacture of microshield handrub at the latter’s production facilities here to be marketed by the former both within the country and abroad .
The product, iso-amyl 2-cyano-acrylate, is used in sutureless surgeries. The import substitute adhesive has demand with applications in ophthalmic, dental, cardiac, ENT, plastic, Orthopedic and general surgeries. It can also be used in blocking tubular tissues, preferably in males. The wound closure tissue glue was developed by Concord Drugs in technical collaboration with the Indian Institute of Chemical Technology (IICT).
According to industry sources, a team from Johnson & Johnson lead by its Regional Director for Asia-Pacific,recently visited Concord’s manufacturing facilities.
Just Look at Daily +Weekly chart :Mouth Watering chart.
Triangle Breakout @ 58…..Indicates 58+17 = 75 level on card.
Falling Trendline Hurdle at 76
Preferential Allotment being done at Rs 80 ,We see Technically if have have patience will cross 100+Nonstop !!
Yesterday Was First Day of Breakout………………Yes Today FRIDAY FREEZE 20% and Monday too…Once World will come to know the NEWS then ??
No comments :
Post a Comment